Qatar Diabetes Mobile Application Trial (QDMAT): an open-label randomised controlled trial to examine the impact of using a mobile application to improve diabetes care in type 2 diabetes mellitus —a study protocol
The objective of the study was to evaluate the effectiveness of the mobile app.MethodsThe planned study is an ongoing open-label randomised controlled trial in which adults living with T2DM treated with insulin will be randomised 1:1 to the use of this diabetes application versus current standard care. The primary outcome will be the difference in mean HbA1c from baseline to 6 months. Other outcome measures include anthropometric measures, hypoglycaemic events, medication adjustments, number of clinical interactions and missed appointments and patient perceptions of their disease and diabetes self-management. The study ...
Source: Trials - June 16, 2022 Category: Research Source Type: clinical trials
Qatar PREgnancy CovId OUtcome Study
Conditions: COVID-19; Pregnant Women Intervention: Sponsor: Hamad Medical Corporation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 27, 2022 Category: Research Source Type: clinical trials
COVID-19 Among Children With Chronic Renal Diseases in Qatar
Conditions: Chronic Kidney Diseases; COVID-19 Infection; Acute Kidney Injury; Chronic Renal Failure in Children; COVID-19 Pandemic Intervention: Other: Medical records review Sponsor: Hamad Medical Corporation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 11, 2022 Category: Research Source Type: clinical trials
